Tag: growth hormone deficiency

OPKO Health acquires Israel’s PROLOR Biotech for $480m

Merger to produce new medications for sufferers of growth hormone deficiency, hemophilia, obesity and diabetes.

Join the Unpacked community

Deepen your understanding of Israel, Judaism, and the Jewish experience to feel more informed, confident, and connected every day. Sign up today to receive: A weekly newsletter, exclusive bonus content across the Unpacked ecosystem, priority access to live events and merch, and members-only community channels.

Tag: growth hormone deficiency

OPKO Health acquires Israel’s PROLOR Biotech for $480m

SUCCESS!